State Street’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.42M | Buy |
|
|||||
|
2025
Q2 | $2.66M | Buy |
|
|||||
|
2025
Q1 | $732K | Buy |
|
|||||
|
2024
Q4 | $1.1M | Buy |
|
|||||
|
2024
Q3 | $941K | Buy |
|
|||||
|
2024
Q2 | $219K | Hold |
|
|||||
|
2024
Q1 | $214K | Sell |
|
|||||
|
2023
Q4 | $244K | Hold |
|
|||||
|
2023
Q3 | $202K | Hold |
|
|||||
|
2023
Q2 | $317K | Buy |
|
|||||
|
2023
Q1 | $102K | Hold |
|
|||||
|
2022
Q4 | $95.7K | Hold |
|
|||||
|
2022
Q3 | $92K | Hold |
|
|||||
|
2022
Q2 | $111K | Hold |
|
|||||
|
2022
Q1 | $185K | Buy |
|
|||||
|
2021
Q4 | $242K | Buy |
|
|||||
|
2021
Q3 | $321K | Buy |
|
|||||
|
2021
Q2 | $79K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $64K | Buy |
|
|||||
|
2019
Q2 | $77K | Sell |
|
|||||
|
2019
Q1 | $854K | Buy |
|
|||||
|
2018
Q4 | $748K | Buy |
|
|||||
|
2018
Q3 | $1.57M | Buy |
|
|||||
|
2018
Q2 | $1.83M | Buy |
|
|||||
|
2018
Q1 | $1.11M | Sell |
|
|||||
|
2017
Q4 | $1M | Buy |
|
|||||
|
2017
Q3 | $1.1M | Buy |
|
|||||
|
2017
Q2 | $756K | Buy |
|
|||||
|
2017
Q1 | $1.09M | Buy |
|
|||||
|
2016
Q4 | $732K | Sell |
|
|||||
|
2016
Q3 | $890K | Buy |
|
|||||
|
2016
Q2 | $407K | Buy |
|